Plunkett Research Online: Vanda Pharmaceuticals Inc

VANDA PHARMACEUTICALS INC (VNDA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vanda Pharmaceuticals Inc. was incorporated in Delaware in 2002. It is a biopharmaceutical Company focusing on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with worldwide commercial rights to two product candidates in clinical develop.....



Vanda Pharmaceuticals Inc
Ticker: VNDA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240 599-4500
Fax: 301 294-1900
Address: 2200 Pennsylvania Avenue NW
Suite 300 E
Washington, DC 20037 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Mihael PolymeropoulosCEO/Co-Founder/Director/President
James KellyCFO/Chief Accounting Officer/Executive VP/Treasurer
See More
Vanda Pharmaceuticals Inc. was incorporated in Delaware in 2002. It is a biopharmaceutical Company focusing on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with worldwide commercial rights to two product candidates in clinical develop.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: